US20160106927A1 - Drug Delivery Device and System with Pre-Set Dose Feature - Google Patents

Drug Delivery Device and System with Pre-Set Dose Feature Download PDF

Info

Publication number: US20160106927A1
Authority: US; United States
Prior art keywords: dose; drug delivery; delivery device; drug; display
Prior art date: 2013-05-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

US14/893,334

Other languages

English (en)

Inventor

Mads Moeller

Michael Svendsmark Hansen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novo Nordisk AS

Original Assignee

Novo Nordisk AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-05-27

Filing date

2014-05-26

Publication date

2016-04-21

2014-05-26 Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS

2016-02-03 Assigned to NOVO NORDISK A/S reassignment NOVO NORDISK A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HANSEN, MICHAEL SVENDSMARK, MOELLER, MADS

2016-04-21 Publication of US20160106927A1 publication Critical patent/US20160106927A1/en

Status Abandoned legal-status Critical Current

Links

238000012377 drug delivery Methods 0.000 title claims abstract description 47
239000003814 drug Substances 0.000 claims abstract description 39
229940079593 drug Drugs 0.000 claims abstract description 38
238000004891 communication Methods 0.000 claims abstract description 10
238000000034 method Methods 0.000 claims description 6
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 26
102000004877 Insulin Human genes 0.000 description 14
108090001061 Insulin Proteins 0.000 description 14
229940125396 insulin Drugs 0.000 description 13
230000008878 coupling Effects 0.000 description 8
238000010168 coupling process Methods 0.000 description 8
238000005859 coupling reaction Methods 0.000 description 8
238000002347 injection Methods 0.000 description 6
239000007924 injection Substances 0.000 description 6
102100025101 GATA-type zinc finger protein 1 Human genes 0.000 description 3
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 3
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 3
238000001514 detection method Methods 0.000 description 3
102000018997 Growth Hormone Human genes 0.000 description 2
108010051696 Growth Hormone Proteins 0.000 description 2
239000003124 biologic agent Substances 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
239000012530 fluid Substances 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000000122 growth hormone Substances 0.000 description 2
239000000203 mixture Substances 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
101000976075 Homo sapiens Insulin Proteins 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000003708 ampul Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000004020 conductor Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
230000009969 flowable effect Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229940124508 injectable medicine Drugs 0.000 description 1
238000007689 inspection Methods 0.000 description 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 1
239000004026 insulin derivative Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000009987 spinning Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
- A61M2005/3126—Specific display means related to dosing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
- A61M2005/31588—Constructional features or modes of drive mechanisms for piston rods electrically driven
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/01—Remote controllers for specific apparatus

Definitions

drug delivery devices have been provided with electrically driven means, typically in the form of an electronically controlled motor driving a piston rod through a gear arrangement, e.g. as shown in U.S. Pat. No. 6,514,230 and US 2011/306927.
electrically driven means typically in the form of an electronically controlled motor driving a piston rod through a gear arrangement, e.g. as shown in U.S. Pat. No. 6,514,230 and US 2011/306927.
the drug delivery device may be provided with first switch means for actuating the device between an idle condition and an activated condition, e.g. an on/off switch, and second switch means for actuating the controller to expel an amount of drug corresponding to a set dose, wherein the controller is adapted to display a stored dose amount when the device is actuated from the idle to the activated condition, e.g. when a protective cap is removed, the stored dose amount representing a pre-set dose. In this way the device is ready to expel the displayed pre-set dose without the user to having to set the dose for each new dosing event.
first switch means for actuating the device between an idle condition and an activated condition
second switch means for actuating the controller to expel an amount of drug corresponding to a set dose
the controller is adapted to display a stored dose amount when the device is actuated from the idle to the activated condition, e.g. when a protective cap is removed, the stored dose amount representing a pre-set dose. In this way
FIG. 3 shows a set-up in which the smartphone is provided with application software allowing a regimen comprising up to three daily injections to be programmed, each alternative being represented by a button.
the display will show all values to be set in a single display view, the values being shown in combination with a period identifier 185 , here “morning” and “evening”.
a period identifier 185 here “morning” and “evening”.
the user can then simply set or adjust the doses to the desired pre-set sizes, the combined showing providing a full overview of the regimen without the need to toggle back and forth between different display showings.
each gripping shoulder is provided with a plurality of gripping teeth spaced circumferentially to provide a plurality of gaps, each tooth having a triangular configuration with a proximally oriented pointed end, thereby creating a plurality of gaps having a distally oriented pointed configuration, this allowing the above-described distally facing pointed projections on the cartridge to be received between the teeth to thereby serve as a gripping means when the cartridge holding means has been moved into engagement with the cartridge.

Landscapes

Health & Medical Sciences (AREA)
Vascular Medicine (AREA)
Engineering & Computer Science (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

US14/893,334 2013-05-27 2014-05-26 Drug Delivery Device and System with Pre-Set Dose Feature Abandoned US20160106927A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP13169352.5		2013-05-27
EP13169352		2013-05-27
PCT/EP2014/060840 WO2014191355A1 (fr)	2013-05-27	2014-05-26	Dispositif et système de libération de médicament avec préréglage de dose

Publications (1)

Publication Number	Publication Date
US20160106927A1 true US20160106927A1 (en)	2016-04-21

Family

ID=48534210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
US14/893,334 Abandoned US20160106927A1 (en)	2013-05-27	2014-05-26	Drug Delivery Device and System with Pre-Set Dose Feature

Country Status (5)

Country	Link
US (1)	US20160106927A1 (fr)
EP (1)	EP3003430A1 (fr)
JP (1)	JP2016525381A (fr)
CN (1)	CN105228672A (fr)
WO (1)	WO2014191355A1 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2019121447A1 (fr) *	2017-12-18	2019-06-27	Sanofi	Dispositif d'injection à commande à distance
US10463787B2 (en)	2017-07-07	2019-11-05	Neuroderm, Ltd.	Device for subcutaneous delivery of fluid medicament
US10864327B2 (en)	2016-01-29	2020-12-15	Companion Medical, Inc.	Automatic medication delivery tracking
US11383043B2 (en)	2017-12-12	2022-07-12	Bigfoot Biomedical, Inc.	Medicine injection and disease management systems, devices, and methods
US11464459B2 (en)	2017-12-12	2022-10-11	Bigfoot Biomedical, Inc.	User interface for diabetes management systems including flash glucose monitor
US11571516B2 (en)	2016-06-06	2023-02-07	E3D Agricultural Cooperative Association	Multiple use computerized injector
US11779697B2 (en)	2017-07-07	2023-10-10	Neuroderm, Ltd.	Device for subcutaneous delivery of fluid medicament
US11844923B2 (en)	2017-12-12	2023-12-19	Bigfoot Biomedical, Inc.	Devices, systems, and methods for estimating active medication from injections
US11896797B2 (en)	2017-12-12	2024-02-13	Bigfoot Biomedical, Inc.	Pen cap for insulin injection pens and associated methods and systems
US11931549B2 (en)	2017-12-12	2024-03-19	Bigfoot Biomedical, Inc.	User interface for diabetes management systems and devices
US11948671B2 (en)	2019-04-11	2024-04-02	Medtronic Minimed, Inc.	Intelligent accessories for medicine dispensing device
US11957884B2 (en)	2017-12-12	2024-04-16	Bigfoot Biomedical, Inc.	Insulin injection assistance systems, methods, and devices
US12205699B1 (en)	2018-10-30	2025-01-21	Bigfoot Biomedical, Inc.	Method of pairing therapy devices using shared secrets, and related systems, methods and devices
US12208251B2 (en)	2017-12-12	2025-01-28	Bigfoot Biomedical, Inc.	Pen cap for medication injection pen having temperature sensor

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106295184B (zh) *	2016-08-10	2018-09-21	深圳先进技术研究院	用于情感康复的智能可穿戴设备

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2572740A (en) *	1948-05-10	1951-10-23	Bell Telephone Labor Inc	Private branch exchange telephone system
US20120033022A1 (en) *	2009-04-30	2012-02-09	Kabalnov Alexey S	Liquid delivery system
US20120330228A1 (en) *	2009-12-01	2012-12-27	Sanofi-Aventis Deutschland Gmbh	Device and method for delivery of two or more drug agents

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS63238870A (ja) *	1987-03-27	1988-10-04	日機装株式会社	プログラム可能な連続微量注入ポンプ
AU8544191A (en)	1990-09-21	1992-04-15	Novo Nordisk A/S	Adaptor top
JP2000042103A (ja) *	1998-07-29	2000-02-15	Terumo Corp	薬液注入システム及びその可読メモリ
US6514230B1 (en)	1999-10-12	2003-02-04	Novo Nordisk A/S	Air shot mechanism for electronic injection devices
JP2004261274A (ja) *	2003-02-28	2004-09-24	Matsushita Electric Ind Co Ltd	注射装置
JP4943728B2 (ja) *	2006-03-30	2012-05-30	テルモ株式会社	血糖計
WO2008091838A2 (fr) *	2007-01-22	2008-07-31	Intelliject, Inc.	Injecteur médical équipé d'un système de détection et de surveillance de l'observance
WO2010100883A1 (fr)	2009-03-04	2010-09-10	パナソニック株式会社	Dispositif de perfusion médicamenteuse
WO2012058694A2 (fr) *	2010-10-31	2012-05-03	Trustees Of Boston University	Système de régulation de la glycémie
AU2011335073B2 (en) *	2010-11-29	2015-02-05	Sanofi-Aventis Deutschland Gmbh	Dispense interface component for a drug delivery device
EP2572740A1 (fr) *	2011-09-20	2013-03-27	Roche Diagnostics GmbH	Dispositifs d'injection de médicaments et systèmes avec un module de mesure de substance à analyser
US9943647B2 (en) *	2011-10-07	2018-04-17	Panasonic Healthcare Holdings Co., Ltd.	Pharmaceutical injection device, method for controlling pharmaceutical injection device, and recording medium
JP6419688B2 (ja)	2012-03-27	2018-11-07	ノボ・ノルデイスク・エー／エス	ピストン近接センシングを有する薬物送達装置

2014
- 2014-05-26 WO PCT/EP2014/060840 patent/WO2014191355A1/fr not_active Ceased
- 2014-05-26 JP JP2016515764A patent/JP2016525381A/ja not_active Withdrawn
- 2014-05-26 CN CN201480030784.0A patent/CN105228672A/zh not_active Withdrawn
- 2014-05-26 EP EP14726590.4A patent/EP3003430A1/fr not_active Withdrawn
- 2014-05-26 US US14/893,334 patent/US20160106927A1/en not_active Abandoned

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2572740A (en) *	1948-05-10	1951-10-23	Bell Telephone Labor Inc	Private branch exchange telephone system
US20120033022A1 (en) *	2009-04-30	2012-02-09	Kabalnov Alexey S	Liquid delivery system
US20120330228A1 (en) *	2009-12-01	2012-12-27	Sanofi-Aventis Deutschland Gmbh	Device and method for delivery of two or more drug agents

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10864327B2 (en)	2016-01-29	2020-12-15	Companion Medical, Inc.	Automatic medication delivery tracking
US11826555B2 (en)	2016-01-29	2023-11-28	Medtronic Minimed, Inc.	Automatic medication delivery tracking
US11571516B2 (en)	2016-06-06	2023-02-07	E3D Agricultural Cooperative Association	Multiple use computerized injector
US11554210B2 (en)	2017-07-07	2023-01-17	Neuroderm, Ltd.	Device for subcutaneous delivery of fluid medicament
US10463787B2 (en)	2017-07-07	2019-11-05	Neuroderm, Ltd.	Device for subcutaneous delivery of fluid medicament
US10463572B2 (en)	2017-07-07	2019-11-05	Neuroderm, Ltd.	Device for subcutaneous delivery of fluid medicament
US10603430B2 (en)	2017-07-07	2020-03-31	Neuroderm, Ltd.	Device for subcutaneous delivery of fluid medicament
US11779697B2 (en)	2017-07-07	2023-10-10	Neuroderm, Ltd.	Device for subcutaneous delivery of fluid medicament
US11464459B2 (en)	2017-12-12	2022-10-11	Bigfoot Biomedical, Inc.	User interface for diabetes management systems including flash glucose monitor
US11918789B2 (en)	2017-12-12	2024-03-05	Bigfoot Biomedical, Inc.	Therapy management systems, methods, and devices
US12364822B2 (en)	2017-12-12	2025-07-22	Bigfoot Biomedical, Inc.	Therapy management systems, methods, and devices
US11771835B2 (en)	2017-12-12	2023-10-03	Bigfoot Biomedical, Inc.	Therapy assist information and/or tracking device and related methods and systems
US12343495B2 (en)	2017-12-12	2025-07-01	Bigfoot Biomedical, Inc.	Devices, systems, and methods for estimating active medication from injections
US11383043B2 (en)	2017-12-12	2022-07-12	Bigfoot Biomedical, Inc.	Medicine injection and disease management systems, devices, and methods
US11844923B2 (en)	2017-12-12	2023-12-19	Bigfoot Biomedical, Inc.	Devices, systems, and methods for estimating active medication from injections
US11896797B2 (en)	2017-12-12	2024-02-13	Bigfoot Biomedical, Inc.	Pen cap for insulin injection pens and associated methods and systems
US11904145B2 (en)	2017-12-12	2024-02-20	Bigfoot Biomedical, Inc.	Diabetes therapy management systems, methods, and devices
US11547805B2 (en)	2017-12-12	2023-01-10	Bigfoot Biomedical, Inc.	Therapy management systems, methods, and devices
US11931549B2 (en)	2017-12-12	2024-03-19	Bigfoot Biomedical, Inc.	User interface for diabetes management systems and devices
US11944465B2 (en)	2017-12-12	2024-04-02	Bigfoot Biomedical, Inc.	Monitor user interface for diabetes management systems including flash glucose
US12290667B2 (en)	2017-12-12	2025-05-06	Bigfoot Biomedical, Inc.	Therapy assist information and/or tracking device and related methods and systems
US11957884B2 (en)	2017-12-12	2024-04-16	Bigfoot Biomedical, Inc.	Insulin injection assistance systems, methods, and devices
US12208251B2 (en)	2017-12-12	2025-01-28	Bigfoot Biomedical, Inc.	Pen cap for medication injection pen having temperature sensor
WO2019121447A1 (fr) *	2017-12-18	2019-06-27	Sanofi	Dispositif d'injection à commande à distance
US11612699B2 (en) *	2017-12-18	2023-03-28	Sanofi	Injection device with a remote control
US12205699B1 (en)	2018-10-30	2025-01-21	Bigfoot Biomedical, Inc.	Method of pairing therapy devices using shared secrets, and related systems, methods and devices
US11948671B2 (en)	2019-04-11	2024-04-02	Medtronic Minimed, Inc.	Intelligent accessories for medicine dispensing device

Also Published As

Publication number	Publication date
CN105228672A (zh)	2016-01-06
JP2016525381A (ja)	2016-08-25
WO2014191355A1 (fr)	2014-12-04
EP3003430A1 (fr)	2016-04-13

Publication	Publication Date	Title
US20160106927A1 (en)	2016-04-21	Drug Delivery Device and System with Pre-Set Dose Feature
EP2981312B1 (fr)	2017-12-27	Système d'administration de médicament avec un moyen de journalisation conçu pour combiner des doses
JP2021000462A (ja)	2021-01-07	クリップ部材上に電子ディスプレイを有するペン型薬剤送達装置
EP3082912B1 (fr)	2018-05-30	Dispositif motorisé d'administration de médicament à caractéristiques de sécurité de charge
US9675761B2 (en)	2017-06-13	Drug delivery device with variable dose setting mechanism
US20170319790A1 (en)	2017-11-09	Drug Delivery Device with Air-in-Cartridge Safety Feature
US20170157340A1 (en)	2017-06-08	Drug Delivery Device with Indicator Guidance
AU2013224349A1 (en)	2014-08-21	Drug delivery device with front loading feature
US20170274148A1 (en)	2017-09-28	Drug delivery device with combined setting and release member
WO2016102526A1 (fr)	2016-06-30	Dispositif d'administration de médicament à ressort
US20170258999A1 (en)	2017-09-14	Drug Delivery Device with Cartridge Centring Feature
US20170290981A1 (en)	2017-10-12	Drug Delivery Device with Piston Driver Distal Feature
EP3595751B1 (fr)	2021-01-27	Ensemble d'administration de médicament avec unité de cartouche
WO2016198540A2 (fr)	2016-12-15	Dispositif d'administration de médicament à capuchon protecteur étendu
JP6756806B2 (ja)	2020-09-16	複数の用量を合算するロギング装置
US20240082499A1 (en)	2024-03-14	Add-on with actuator for a drug delivery device

Legal Events

Date	Code	Title	Description
2016-02-03	AS	Assignment	Owner name: NOVO NORDISK A/S, DENMARK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MOELLER, MADS;HANSEN, MICHAEL SVENDSMARK;REEL/FRAME:037656/0088 Effective date: 20151214
2019-02-18	STCB	Information on status: application discontinuation	Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

Date

Code

Title

Description

2016-02-03

Assignment

Owner name: NOVO NORDISK A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MOELLER, MADS;HANSEN, MICHAEL SVENDSMARK;REEL/FRAME:037656/0088

Effective date: 20151214

2019-02-18

STCB

Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION